The global metagenomics sequencing market size was US$ 1139.3 million in 2021. The global metagenomics sequencing market is forecast to grow to US$ 3,994.01 million by 2030 by registering a compound ...
Researchers from Nazarbayev University's National Laboratory created the first large-scale, high-quality genotyping dataset ...
Everyday Health on MSN
The 9 best doctor-recommended red light therapy masks on the market
Red light range: Pay attention to the wavelengthsred light typically falls between 630660 nanometers, while near-infrared is usually around 830 nanometers, says Dr. Henry. Look for masks that fall ...
Illumina, Inc. today announced that members of its management team will participate at the following investor conference: Upcoming Investor Conference44th Annual J.P. Morgan Healthcare Conference on ...
Illumina (ILMN) shares have shown steady movement recently, catching the attention of investors looking at biotech trends. With its latest quarterly performance, investors are considering how ongoing ...
Illumina exhibits better profitability ratios than many of its peers, which indicates that the company could continue to invest in its operations. In Q3 2025, ILMN raised its EPS to $4.65-$4.75, ...
Illumina’s revenue was flat for the third quarter as the sequencing giant continues to deal with headwinds from a China sales ban. The $1.08 billion it brought in for the third quarter was, however, ...
Revenue: $1.08 billion, roughly flat year-over-year, exceeded guidance range. Non-GAAP Operating Margin: 24.5%, expanded by 190 basis points year-over-year. Non-GAAP Diluted EPS: $1.34, grew $0.20 ...
Illumina announced today it has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data-driven proteomics technology, for up to $425 ...
Illumina lowered its annual financial forecast and says it plans to cut about $100 million in costs after China banned imports of its gene sequencers last week. The San Diego maker of gene-sequencing ...
Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China barred sales of the company’s gene-sequencing machines. San Diego-based ...
The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the gene-sequencing company from importing its machines to the country. It’s part ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results